Perdagangan Asensus Surgical, Inc. - ASXC CFD
Tambah ke favorit- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
Spread | 0.0442 | ||||||||
Biaya inap posisi Long
Long position overnight fee
Kunjungi platform | -0.030779% | ||||||||
Biaya inap posisi short
Short position overnight fee
Kunjungi platform | -0.013666% | ||||||||
Waktu biaya inap | 22:00 (UTC) | ||||||||
Kuantitas min. yang diperdagangkan | 1 | ||||||||
Mata uang | USD | ||||||||
Margin | 20% | ||||||||
Bursa efek | United States of America | ||||||||
Komisi perdagangan | 0% |
*Information provided by Capital.com
Key Stats
Prev. Close* | 0.7236 |
Open* | 0.7328 |
1-Year Change* | -4.83% |
Day's Range* | 0.6666 - 0.7332 |
52 wk Range | 0.28-0.92 |
Average Volume (10 days) | 1.95M |
Average Volume (3 months) | 25.16M |
Market Cap | 163.51M |
P/E Ratio | -100.00K |
Shares Outstanding | 236.84M |
Revenue | 7.10M |
EPS | -0.31 |
Dividend (Yield %) | N/A |
Beta | 1.80 |
Next Earnings Date | Feb 27, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 7, 2023 | 0.7236 | 0.0678 | 10.34% | 0.6558 | 0.7380 | 0.6483 |
Feb 6, 2023 | 0.6688 | 0.0803 | 13.64% | 0.5885 | 0.6853 | 0.5885 |
Feb 3, 2023 | 0.7311 | 0.0070 | 0.97% | 0.7241 | 0.7748 | 0.7181 |
Feb 2, 2023 | 0.7201 | -0.0244 | -3.28% | 0.7445 | 0.7723 | 0.7167 |
Feb 1, 2023 | 0.7239 | -0.0658 | -8.33% | 0.7897 | 0.7948 | 0.6683 |
Jan 31, 2023 | 0.7715 | -0.0313 | -3.90% | 0.8028 | 0.8268 | 0.7680 |
Jan 30, 2023 | 0.7980 | 0.0200 | 2.57% | 0.7780 | 0.8346 | 0.7780 |
Jan 27, 2023 | 0.7981 | -0.0010 | -0.13% | 0.7991 | 0.8546 | 0.7580 |
Jan 26, 2023 | 0.8093 | 0.1239 | 18.08% | 0.6854 | 0.8294 | 0.6683 |
Jan 25, 2023 | 0.6726 | 0.0043 | 0.64% | 0.6683 | 0.6882 | 0.6583 |
Jan 24, 2023 | 0.6677 | -0.0277 | -3.98% | 0.6954 | 0.6954 | 0.6611 |
Jan 23, 2023 | 0.6597 | 0.0114 | 1.76% | 0.6483 | 0.7028 | 0.6483 |
Jan 20, 2023 | 0.6416 | -0.0167 | -2.54% | 0.6583 | 0.6803 | 0.6284 |
Jan 19, 2023 | 0.6481 | 0.0024 | 0.37% | 0.6457 | 0.6660 | 0.6084 |
Jan 18, 2023 | 0.5981 | -0.0973 | -13.99% | 0.6954 | 0.7099 | 0.5885 |
Jan 17, 2023 | 0.6583 | 0.0424 | 6.88% | 0.6159 | 0.7172 | 0.6084 |
Jan 13, 2023 | 0.5865 | 0.1246 | 26.98% | 0.4619 | 0.5931 | 0.4588 |
Jan 12, 2023 | 0.4682 | 0.0252 | 5.69% | 0.4430 | 0.4740 | 0.4291 |
Jan 11, 2023 | 0.4409 | 0.0039 | 0.89% | 0.4370 | 0.4486 | 0.4370 |
Jan 10, 2023 | 0.4438 | 0.0051 | 1.16% | 0.4387 | 0.4484 | 0.4189 |
Asensus Surgical, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 1.519 | 7.111 | 24.102 | 8.531 | 3.175 | 8.232 |
Revenue | 1.519 | 7.111 | 24.102 | 8.531 | 3.175 | 8.232 |
Cost of Revenue, Total | 1.069 | 6.727 | 16.171 | 20.731 | 5.166 | 11.096 |
Gross Profit | 0.45 | 0.384 | 7.931 | -12.2 | -1.991 | -2.864 |
Total Operating Expense | 125.168 | 69.038 | 73.254 | 163.106 | 63.564 | 70.004 |
Selling/General/Admin. Expenses, Total | 19.964 | 29.811 | 39.59 | 46.772 | 27.201 | 32.718 |
Research & Development | 29.273 | 21.989 | 21.823 | 22.468 | 16.621 | 19.348 |
Depreciation / Amortization | 6.967 | 7.858 | 10.868 | 10.301 | 10.801 | 11.254 |
Unusual Expense (Income) | 67.413 | 0 | -14.187 | 72.387 | 0.851 | -2.847 |
Other Operating Expenses, Total | 0.482 | 2.653 | -1.011 | -9.553 | 2.924 | -1.565 |
Operating Income | -123.649 | -61.927 | -49.152 | -154.575 | -60.389 | -61.772 |
Interest Income (Expense), Net Non-Operating | -1.889 | -85.869 | -17.128 | -1.783 | -0.32 | -1.761 |
Other, Net | 0.035 | -0.3 | 1.126 | -0.967 | -0.119 | 1.296 |
Net Income Before Taxes | -125.503 | -148.096 | -65.154 | -157.325 | -60.828 | -62.237 |
Net Income After Taxes | -119.98 | -144.796 | -61.777 | -154.201 | -59.312 | -62.462 |
Net Income Before Extra. Items | -119.98 | -144.796 | -61.777 | -154.201 | -59.312 | -62.462 |
Net Income | -119.98 | -144.796 | -61.777 | -154.201 | -59.312 | -62.462 |
Income Available to Common Excl. Extra. Items | -119.98 | -144.796 | -61.777 | -154.201 | -60.023 | -62.462 |
Income Available to Common Incl. Extra. Items | -119.98 | -144.796 | -61.777 | -154.201 | -60.023 | -62.462 |
Diluted Net Income | -119.98 | -144.796 | -61.777 | -154.201 | -60.023 | -62.462 |
Diluted Weighted Average Shares | 8.62962 | 11.4418 | 15.9384 | 17.737 | 70.809 | 226.96 |
Diluted EPS Excluding Extraordinary Items | -13.9033 | -12.655 | -3.87599 | -8.69375 | -0.84767 | -0.27521 |
Diluted Normalized EPS | -8.8256 | -12.655 | -4.45456 | -5.88489 | -0.83986 | -0.28337 |
Total Extraordinary Items | 0 | |||||
Total Adjustments to Net Income | -0.711 | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 2.083 | 1.102 | 2.571 | 2.476 | 1.066 |
Revenue | 2.083 | 1.102 | 2.571 | 2.476 | 1.066 |
Cost of Revenue, Total | 3.112 | 2.347 | 3.35 | 2.287 | 1.823 |
Gross Profit | -1.029 | -1.245 | -0.779 | 0.189 | -0.757 |
Total Operating Expense | 17.496 | 14.339 | 20.009 | 18.16 | 20.019 |
Selling/General/Admin. Expenses, Total | 7.045 | 7.41 | 9.108 | 9.155 | 9.252 |
Research & Development | 4.215 | 4.089 | 4.469 | 6.575 | 6.428 |
Depreciation / Amortization | 2.867 | 2.862 | 2.804 | 2.721 | 2.67 |
Unusual Expense (Income) | 0 | -2.847 | 0 | 0 | |
Other Operating Expenses, Total | 0.257 | 0.478 | 0.278 | -2.578 | -0.154 |
Operating Income | -15.413 | -13.237 | -17.438 | -15.684 | -18.953 |
Interest Income (Expense), Net Non-Operating | -1.936 | 0.074 | 0.057 | 0.044 | 0.055 |
Other, Net | -0.029 | -0.007 | 1.344 | -0.012 | -0.146 |
Net Income Before Taxes | -17.378 | -13.17 | -16.037 | -15.652 | -19.044 |
Net Income After Taxes | -17.34 | -13.172 | -16.069 | -15.881 | -19.128 |
Net Income Before Extra. Items | -17.34 | -13.172 | -16.069 | -15.881 | -19.128 |
Net Income | -17.34 | -13.172 | -16.069 | -15.881 | -19.128 |
Total Adjustments to Net Income | 0 | 0 | 0 | 0 | |
Income Available to Common Excl. Extra. Items | -17.34 | -13.172 | -16.069 | -15.881 | -19.128 |
Income Available to Common Incl. Extra. Items | -17.34 | -13.172 | -16.069 | -15.881 | -19.128 |
Diluted Net Income | -17.34 | -13.172 | -16.069 | -15.881 | -19.128 |
Diluted Weighted Average Shares | 204.992 | 233.25 | 234.337 | 234.94 | 235.892 |
Diluted EPS Excluding Extraordinary Items | -0.08459 | -0.05647 | -0.06857 | -0.0676 | -0.08109 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.08459 | -0.06441 | -0.06857 | -0.0676 | -0.08109 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 38.016 | 112.994 | 101.583 | 27.955 | 34.013 | 113.297 |
Cash and Short Term Investments | 24.165 | 91.217 | 72.851 | 9.598 | 16.363 | 98.391 |
Cash & Equivalents | 24.165 | 91.217 | 21.061 | 9.598 | 16.363 | 18.129 |
Total Receivables, Net | 1.976 | 3.038 | 8.595 | 3.336 | 3.985 | 2.06 |
Accounts Receivable - Trade, Net | 0.621 | 1.536 | 8.56 | 0.62 | 1.115 | 0.749 |
Total Inventory | 7.883 | 10.817 | 10.941 | 10.653 | 10.034 | 8.634 |
Prepaid Expenses | 3.992 | 7.922 | 9.196 | 4.368 | 3.631 | 3.255 |
Total Assets | 176.249 | 250.251 | 239.307 | 74.779 | 78.258 | 186.473 |
Property/Plant/Equipment, Total - Net | 5.772 | 6.67 | 6.337 | 7.006 | 11.542 | 16.319 |
Property/Plant/Equipment, Total - Gross | 12.345 | 15.888 | 17.499 | 17.974 | 25.802 | 26.008 |
Accumulated Depreciation, Total | -6.573 | -9.218 | -11.162 | -10.968 | -14.26 | -9.689 |
Goodwill, Net | 68.697 | 71.368 | 80.131 | 0 | ||
Intangibles, Net | 53.01 | 52.638 | 50.463 | 31.066 | 22.267 | 9.892 |
Note Receivable - Long Term | 0.266 | 0 | ||||
Other Long Term Assets, Total | 10.488 | 6.581 | 0.793 | 8.752 | 10.436 | 9.53 |
Total Current Liabilities | 30.689 | 28.84 | 21.819 | 13.023 | 10.283 | 9.85 |
Accounts Payable | 3.984 | 3.771 | 4.433 | 3.579 | 1.965 | 3.448 |
Accrued Expenses | 7.883 | 10.379 | 9.228 | 8.553 | 6.301 | 5.859 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.997 | 4.788 | 0 | 1.228 | 0 | |
Other Current Liabilities, Total | 10.825 | 9.902 | 8.158 | 0.891 | 0.789 | 0.543 |
Total Liabilities | 58.379 | 71.403 | 70.786 | 19.244 | 16.689 | 17.227 |
Total Long Term Debt | 4.995 | 8.385 | 28.937 | 0 | 1.587 | 0 |
Long Term Debt | 4.995 | 8.385 | 28.937 | 0 | 1.587 | 0 |
Deferred Income Tax | 10.397 | 8.389 | 4.72 | 1.392 | 0 | |
Other Liabilities, Total | 12.298 | 25.789 | 15.31 | 4.829 | 4.819 | 7.377 |
Total Equity | 117.87 | 178.848 | 168.521 | 55.535 | 61.569 | 169.246 |
Common Stock | 0.115 | 0.199 | 0.216 | 0.021 | 0.116 | 0.235 |
Additional Paid-In Capital | 426.609 | 621.261 | 676.373 | 720.484 | 781.397 | 954.649 |
Retained Earnings (Accumulated Deficit) | -302.844 | -447.64 | -509.406 | -663.6 | -722.912 | -785.374 |
Treasury Stock - Common | -0.241 | 0 | ||||
Other Equity, Total | -5.769 | 5.028 | 1.338 | -1.37 | 2.968 | -0.264 |
Total Liabilities & Shareholders’ Equity | 176.249 | 250.251 | 239.307 | 74.779 | 78.258 | 186.473 |
Total Common Shares Outstanding | 8.89867 | 15.3288 | 16.6413 | 20.6913 | 116.231 | 235.219 |
Short Term Investments | 51.79 | 0 | 80.262 | |||
Redeemable Preferred Stock | 0 | 0 | ||||
Total Preferred Shares Outstanding | 0 | |||||
Other Current Assets, Total | 0.957 | |||||
Long Term Investments | 37.435 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 182.325 | 174.007 | 134.807 | 113.297 | 118.684 |
Cash and Short Term Investments | 165.245 | 157.078 | 117.751 | 98.391 | 103.741 |
Cash & Equivalents | 165.245 | 157.078 | 59.779 | 18.129 | 24.828 |
Total Receivables, Net | 2.306 | 0.96 | 2.266 | 2.06 | 1.841 |
Accounts Receivable - Trade, Net | 2.306 | 0.96 | 0.955 | 0.749 | 0.53 |
Total Inventory | 11.181 | 12.523 | 11.954 | 8.634 | 9.141 |
Other Current Assets, Total | 3.593 | 3.446 | 0.627 | 0.957 | 0.935 |
Total Assets | 223.615 | 212.004 | 199.759 | 186.473 | 166.56 |
Property/Plant/Equipment, Total - Net | 13.413 | 13.975 | 14.239 | 16.319 | 15.523 |
Intangibles, Net | 18.591 | 15.943 | 12.82 | 9.892 | 7.009 |
Other Long Term Assets, Total | 9.286 | 8.079 | 7.751 | 9.53 | 10.617 |
Total Current Liabilities | 9.508 | 8.307 | 9.421 | 9.85 | 8.653 |
Accounts Payable | 2.327 | 2.653 | 3.231 | 3.448 | 3.521 |
Accrued Expenses | 3.83 | 4.868 | 5.512 | 5.859 | 4.599 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2.459 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 0.892 | 0.786 | 0.678 | 0.543 | 0.533 |
Total Liabilities | 17.697 | 16.443 | 18.258 | 17.227 | 15.735 |
Total Long Term Debt | 0.356 | 0 | 0 | 0 | 0 |
Long Term Debt | 0.356 | 0 | 0 | 0 | |
Other Liabilities, Total | 7.833 | 8.136 | 8.837 | 7.377 | 7.082 |
Total Equity | 205.918 | 195.561 | 181.501 | 169.246 | 150.825 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.233 | 0.234 | 0.234 | 0.235 | 0.236 |
Additional Paid-In Capital | 944.907 | 947.249 | 950.242 | 954.649 | 956.557 |
Retained Earnings (Accumulated Deficit) | -740.252 | -753.424 | -769.493 | -785.374 | -804.502 |
Other Equity, Total | 1.03 | 1.502 | 0.518 | -0.264 | -1.466 |
Total Liabilities & Shareholders’ Equity | 223.615 | 212.004 | 199.759 | 186.473 | 166.56 |
Total Common Shares Outstanding | 232.717 | 234.231 | 234.37 | 235.219 | 236.415 |
Total Preferred Shares Outstanding | 0 | 0 | |||
Short Term Investments | 57.972 | 80.262 | 78.913 | ||
Prepaid Expenses | 2.209 | 3.255 | 3.026 | ||
Long Term Investments | 30.142 | 37.435 | 14.727 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | -119.98 | -144.796 | -61.777 | -154.201 | -59.312 | -62.462 |
Cash From Operating Activities | -52.386 | -47.295 | -48.493 | -73.484 | -46.675 | -40.659 |
Cash From Operating Activities | 1.942 | 2.486 | 2.42 | 2.166 | 2.898 | 2.857 |
Amortization | 6.967 | 7.858 | 10.868 | 10.301 | 10.801 | 11.254 |
Deferred Taxes | -5.562 | -3.3 | -3.377 | -3.224 | -1.516 | 0.225 |
Non-Cash Items | 70.148 | 94.494 | 9.288 | 76.825 | 11.171 | 6.24 |
Cash Interest Paid | 1.289 | 0.899 | 1.73 | 2.187 | 0 | 0 |
Changes in Working Capital | -5.901 | -4.037 | -5.915 | -5.351 | -10.717 | 1.227 |
Cash From Investing Activities | -1.361 | 5.509 | -53.481 | 67.645 | -0.003 | -119.668 |
Capital Expenditures | -1.361 | -1.991 | -0.77 | -0.437 | -0.003 | -1.368 |
Cash From Financing Activities | 49.943 | 104.371 | 26.452 | -5.609 | 53.37 | 161.705 |
Financing Cash Flow Items | -1.35 | -7.349 | -2.432 | -0.499 | -0.11 | -1.063 |
Issuance (Retirement) of Stock, Net | 58.195 | 112.058 | 15.682 | 26.315 | 50.665 | 162.768 |
Issuance (Retirement) of Debt, Net | -6.902 | -0.338 | 13.202 | -31.425 | 2.815 | 0 |
Foreign Exchange Effects | -0.055 | 0.431 | -0.433 | 0.364 | 0.27 | 0.376 |
Net Change in Cash | -3.859 | 63.016 | -75.955 | -11.084 | 6.962 | 1.754 |
Other Investing Cash Flow Items, Total | 7.5 | -52.711 | 68.082 | 0 | -118.3 | |
Cash Taxes Paid | -0.17 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.34 | -30.512 | -46.581 | -62.462 | -19.128 |
Cash From Operating Activities | -10.237 | -18.485 | -27.487 | -40.659 | -15.943 |
Cash From Operating Activities | 0.802 | 1.585 | 2.416 | 2.857 | 0.869 |
Amortization | 2.867 | 5.729 | 8.533 | 11.254 | 2.67 |
Deferred Taxes | -0.038 | -0.036 | -0.004 | 0.225 | 0.084 |
Non-Cash Items | 4.146 | 3.785 | 5.867 | 6.24 | 2.303 |
Changes in Working Capital | -0.674 | 0.964 | 2.282 | 1.227 | -2.741 |
Cash From Investing Activities | -0.395 | -0.7 | -89.07 | -119.668 | 23.045 |
Capital Expenditures | -0.395 | -0.7 | -0.838 | -1.368 | -0.246 |
Cash From Financing Activities | 159.605 | 160.108 | 160.141 | 161.705 | -0.336 |
Financing Cash Flow Items | -0.214 | -1.041 | -1.058 | -1.063 | -0.348 |
Issuance (Retirement) of Stock, Net | 159.819 | 161.149 | 161.199 | 162.768 | 0.012 |
Foreign Exchange Effects | -0.108 | -0.329 | -0.181 | 0.376 | -0.045 |
Net Change in Cash | 148.865 | 140.594 | 43.403 | 1.754 | 6.721 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | ||
Other Investing Cash Flow Items, Total | -88.232 | -118.3 | 23.291 | ||
Cash Interest Paid | 0 | ||||
Cash Taxes Paid | -0.029 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.8268 | 11431792 | 575904 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.5426 | 3653424 | -20584 | 2022-09-30 | LOW |
Millennium Management LLC | Hedge Fund | 1.1492 | 2721843 | -2318995 | 2022-09-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9254 | 2191771 | 4666 | 2022-09-30 | LOW |
GSA Capital Partners LLP | Hedge Fund | 0.4227 | 1001158 | 629411 | 2022-09-30 | HIGH |
Ergoteles Capital | Hedge Fund | 0.4087 | 967987 | -75876 | 2022-09-30 | HIGH |
Fernando (Anthony C J) | Individual Investor | 0.3475 | 823117 | 0 | 2022-04-18 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.345 | 817129 | 0 | 2022-12-31 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.308 | 729462 | -243844 | 2022-09-30 | LOW |
Milne David Bruce | Individual Investor | 0.2617 | 619884 | 0 | 2022-04-18 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.2491 | 590010 | 171230 | 2022-09-30 | LOW |
SV Health Investors, LLC | Venture Capital | 0.2154 | 510142 | 0 | 2022-09-30 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1753 | 415150 | 0 | 2022-09-30 | LOW |
Hsiao (Jane H) | Individual Investor | 0.1422 | 336895 | 0 | 2022-04-18 | |
T. Rowe Price International Ltd | Investment Advisor/Hedge Fund | 0.125 | 296100 | 296100 | 2022-09-30 | MED |
DWS Investment Management Americas, Inc. | Investment Advisor/Hedge Fund | 0.1219 | 288600 | 0 | 2022-09-30 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 0.1196 | 283376 | -237674 | 2022-09-30 | MED |
Advisor Group, Inc | Investment Advisor | 0.0903 | 213840 | 22666 | 2022-09-30 | LOW |
Caption Management, LLC | Hedge Fund | 0.085 | 201243 | 0 | 2022-09-30 | HIGH |
Biffi (Andrea) | Individual Investor | 0.0843 | 199738 | 0 | 2022-04-18 |
Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.
Capital.com Group +500000+
Trader
93000+
Klien aktif per bulan
$57000000+
Volume investasi per bulan
$31000000+
Coba sekarang Penarikan tiap bulan
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1 Tw Alexander Drive
Suite 160
DURHAM
NORTH CAROLINA 27703
US
Income Statement
- Annual
- Quarterly
People also watch
Masih mencari broker yang bisa Anda percayai?
Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com